Eurobio Scientific SA Net Asset Quality Index
Eurobio Scientific SA net asset quality index. Eurobio Scientific SA (ALERS) has a Net Asset Quality Index of 69.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €259.11 Million minus total liabilities of €78.26 Million yields net assets of €180.85 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Eurobio Scientific SA book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Eurobio Scientific SA (2007–2024)
Net asset quality index of Eurobio Scientific SA from 2007 to 2024. This chart shows how Eurobio Scientific SA's Net Asset Quality Index has evolved across 18 annual periods from 2007 to 2024. As of June 2025, the index stands at 69.8%, representing net assets of €180.85 Million against total assets of €259.11 Million EUR. Check ALERS strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Eurobio Scientific SA Net Asset Quality Index by Year (2007–2024)
Eurobio Scientific SA net asset quality index by year from 2007 to 2024. The table below presents the year-by-year Net Asset Quality Index for Eurobio Scientific SA from 2007 to 2024, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ALERS market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.5% | €178.85 Million | €257.17 Million | €78.31 Million | ▲ +14.2 pp |
| 2023 | 55.4% | €175.17 Million | €316.33 Million | €141.16 Million | ▲ +3.1 pp |
| 2022 | 52.3% | €172.67 Million | €330.42 Million | €157.75 Million | ▼ -24.3 pp |
| 2021 | 76.6% | €160.22 Million | €209.22 Million | €49.00 Million | ▲ +14.0 pp |
| 2020 | 62.6% | €107.84 Million | €172.30 Million | €64.45 Million | ▲ +17.5 pp |
| 2019 | 45.1% | €36.56 Million | €81.01 Million | €44.44 Million | ▲ +2.8 pp |
| 2018 | 42.4% | €29.62 Million | €69.90 Million | €40.27 Million | ▼ -1.9 pp |
| 2017 | 44.3% | €31.69 Million | €71.57 Million | €39.88 Million | ▲ +5.9 pp |
| 2016 | 38.3% | €12.23 Million | €31.89 Million | €19.66 Million | ▼ -26.9 pp |
| 2015 | 65.3% | €23.31 Million | €35.71 Million | €12.40 Million | ▼ -3.7 pp |
| 2014 | 69.0% | €27.95 Million | €40.50 Million | €12.55 Million | ▲ +7.5 pp |
| 2013 | 61.5% | €20.56 Million | €33.41 Million | €12.85 Million | ▼ -2.1 pp |
| 2012 | 63.6% | €24.50 Million | €38.49 Million | €13.99 Million | ▼ -13.4 pp |
| 2011 | 77.1% | €13.57 Million | €17.60 Million | €4.04 Million | ▲ +15.7 pp |
| 2010 | 61.4% | €19.19 Million | €31.26 Million | €12.07 Million | ▼ -8.3 pp |
| 2009 | 69.7% | €25.46 Million | €36.55 Million | €11.09 Million | ▲ +37.0 pp |
| 2008 | 32.6% | €9.74 Million | €29.85 Million | €20.11 Million | ▼ -15.4 pp |
| 2007 | 48.1% | €18.07 Million | €37.59 Million | €19.52 Million | — |